Celltrion
068270.KS
#803
Rank
C$40.10 B
Marketcap
C$183.33
Share price
6.00%
Change (1 day)
5.26%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): C$2.64

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$2.61. In 2024 the company made an earnings per share (EPS) of C$1.85 a decrease over its 2023 EPS that were of C$3.66.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$2.6442.68%
2024C$1.85-49.57%
2023C$3.66-2.08%
2022C$3.74-11.72%
2021C$4.242.03%
2020C$4.1582.8%
2019C$2.2718.31%
2018C$1.92-36.33%
2017C$3.02161.25%
2016C$1.152.86%
2015C$1.1217.84%
2014C$0.955.87%
2013C$0.90-70.85%
2012C$3.09134.09%
2011C$1.3243.59%
2010C$0.9274.49%
2009C$0.53317.8%
2008C$0.13-71.7%
2007C$0.45